Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Herceptin
Pharma
Merck's Keytruda mostly won out at ESMO, with one notable miss
At this year's ESMO conference in Spain, Merck unleashed a flurry of studies showing Keytruda’s power and its limitations.
Fraiser Kansteiner
Oct 24, 2023 9:05am
Genentech lays off 280 as first biologics plant winds down
Mar 23, 2023 9:40am
Roche pharma CEO Anderson leaves in another leadership shuffle
Dec 12, 2022 9:52am
Seagen's Tukysa picks up FDA priority review in Herceptin combo
Sep 20, 2022 10:59am
AZ, Daiichi's Enhertu, after 2 recent nods, notches trial win
Aug 15, 2022 11:45am
Opdivo-Yervoy flops 2 stomach cancer trials
Sep 19, 2021 9:05am
